IRIS
FERRARI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.721
AS - Asia 6.419
EU - Europa 4.176
SA - Sud America 1.067
AF - Africa 369
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 18.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.558
SG - Singapore 2.665
CN - Cina 1.983
IE - Irlanda 933
BR - Brasile 860
SE - Svezia 704
IT - Italia 659
HK - Hong Kong 575
DE - Germania 468
VN - Vietnam 401
FI - Finlandia 397
TR - Turchia 363
NL - Olanda 269
ZA - Sudafrica 262
FR - Francia 189
CA - Canada 100
UA - Ucraina 99
GB - Regno Unito 97
IN - India 97
RU - Federazione Russa 91
AR - Argentina 81
JP - Giappone 48
BD - Bangladesh 46
KR - Corea 43
CI - Costa d'Avorio 42
MX - Messico 42
IQ - Iraq 39
AT - Austria 37
BE - Belgio 37
PL - Polonia 36
EC - Ecuador 34
DK - Danimarca 29
ES - Italia 26
ID - Indonesia 26
CO - Colombia 25
PK - Pakistan 25
LT - Lituania 21
VE - Venezuela 19
MA - Marocco 17
RO - Romania 17
UZ - Uzbekistan 17
PY - Paraguay 16
CZ - Repubblica Ceca 14
KE - Kenya 14
AU - Australia 13
EG - Egitto 10
PE - Perù 9
AZ - Azerbaigian 8
IL - Israele 8
UY - Uruguay 8
BG - Bulgaria 7
BO - Bolivia 7
CL - Cile 7
GR - Grecia 7
PA - Panama 7
TW - Taiwan 7
CH - Svizzera 6
IR - Iran 6
KZ - Kazakistan 6
MY - Malesia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
JO - Giordania 5
PT - Portogallo 5
TN - Tunisia 5
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
BB - Barbados 3
BY - Bielorussia 3
EE - Estonia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TG - Togo 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
SN - Senegal 2
TZ - Tanzania 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
Totale 18.757
Salva come PNG Salva come JPEG
Città #
Singapore 1.250
Dublin 932
Ashburn 824
Chandler 729
Santa Clara 612
Hong Kong 572
Dallas 500
Beijing 439
Dearborn 409
Izmir 300
Boardman 280
Nanjing 250
Johannesburg 246
Princeton 200
Munich 195
Parma 194
Shanghai 156
Ann Arbor 155
Wilmington 151
Ho Chi Minh City 148
Helsinki 132
Los Angeles 130
New York 130
Jacksonville 107
Columbus 106
Hanoi 90
São Paulo 87
Shenyang 77
Hebei 74
Hefei 65
Nanchang 64
Moscow 62
Tianjin 59
Kunming 54
Seattle 53
Milan 52
Jinan 51
Chicago 49
The Dalles 47
Guangzhou 45
Tokyo 45
Düsseldorf 44
Abidjan 42
Grafing 42
Toronto 42
Changsha 41
Jiaxing 41
Buffalo 40
Rio de Janeiro 40
Bremen 39
Kocaeli 39
San Mateo 35
Houston 34
Norwalk 34
Stockholm 34
Brussels 32
Rome 31
Des Moines 30
Montreal 30
Zhengzhou 30
London 28
Turku 28
Frankfurt am Main 27
Nuremberg 27
Bologna 26
Seoul 26
Warsaw 26
San Jose 25
Vienna 25
Council Bluffs 23
Taastrup 23
Brooklyn 22
Hangzhou 21
Marseille 21
Mestre 21
Phoenix 21
Belo Horizonte 20
Da Nang 19
Atlanta 18
Brasília 18
Denver 18
Curitiba 17
Jakarta 17
Pune 17
Bengaluru 16
Tashkent 16
Washington 16
Baghdad 15
Haiphong 15
Ningbo 15
Orem 15
Rockville 15
Ardea 14
Chennai 14
Hải Dương 14
Boston 13
Chengdu 13
Guarulhos 13
Mexico City 13
Salvador 13
Totale 11.585
Salva come PNG Salva come JPEG
Nome #
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 261
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 255
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 236
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 227
A simplified sars-cov-2 pseudovirus neutralization assay 176
The anti-COVID-19 vaccine unveils latent systemic sclerosis 172
Therapeutic potential of co-signaling receptor modulation in hepatitis B 148
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study 147
Metabolic regulation of the HBV-specific T cell function 146
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 143
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 141
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 136
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients 135
ALTERAZIONI DELLA FUNZIONALITA’ TIROIDEA IN PAZIENTI AFFETTI DA EPATITE CRONICA ATTIVA DA VIRUS C IN TERAPIA CON INTERFERONE E RIBAVIRINA E CORRELAZIONE CON LA RISPOSTA ALLA TERAPIA ANTIVIRALE 135
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 134
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 132
Adaptive immunity in HBV infection 130
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 128
[An outbreak type A hepatitis in a family group living in a village near Parma. Epidemiologic evaluation and prophylaxis (author's transl)] 128
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 128
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 127
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 126
Alterazioni della funzionalità tiroidea in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone e ribavirina e correlazione con la risposta alla terapia antivirale. 125
Le linee di ricerca strategiche di un'azienda ospedaliero-universitaria: proposta di un metodo qualiquantitativo 125
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 124
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 124
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 122
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 122
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV. J. Hepatol. 119
HBV immune-therapy: From molecular mechanisms to clinical applications 119
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 119
T cell regulation in HBV-related chronic liver disease 118
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 117
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 117
Tiroiditi distruttive in pazienti affetti da epatite cronica attiva da virus C in terapia con interferone: nostra esperienza 117
STUDIO E COMPARAZIONE DELLE ALTERAZIONI DI FUNZIONALITA’ TIROIDEA INDOTTE DA INTERFERONE NEI SOGGETTI CON EPATITE CRONICA ATTIVA DA VIRUS C RISPETTO A SOGGETTI DI CONTROLLO 116
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 114
Course of Graves' disease in interferon-treated patients with chronic hepatitis C virus infection and in uninfected patients 112
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 112
[Infectious agents in the G.I. tract diseases (author's transl)] 108
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 108
Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV 107
Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study 106
COMPOSTO FARMACEUTICO PER L’USO IN UN TRATTAMENTO TERAPEUTICO DELL’INFEZIONE CRONICA DA HBV E METODO PER L’IDENTIFICAZIONE DI LINFOCITI ESAURITI 105
What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group 105
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 105
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 105
Clinical spectrum of cryoglobulinaemic neuropathy 104
RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection 104
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection 101
[The cell-mediated antiviral immune response. The possible therapeutic implications for chronic hepatitis B viral infection] 100
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 100
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 97
Fine specificity of the human T cell response to hepatitis B virus core antigen 97
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 97
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B 96
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 96
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 95
Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C? 94
Clinical features of hepatitis delta virus infection in a northern Italian area 94
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 93
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection 93
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 92
Immune pathogenesis of hepatitis B 92
[Non-A, non-B hepatitis. Seroimmunological, epidemiological and clinical findings] 92
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines 92
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probably related to integrase inhibitor use 92
Practice of proctology among general surgery residents and young specialists in Italy: a snapshot survey 91
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 91
Graves Disease In Interferon - Treated and Untreated Patients with Chronic Hepatitis C Virus Infection 91
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 91
A global scientific strategy to cure hepatitis B 90
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 89
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 89
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 89
Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. 89
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 89
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 88
New perspectives for T-cell-based HCV vaccines 88
[The immunopathogenesis of hepatitis B] 88
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 87
T and B Cells in Hepatitis C Virus Control: What They Do and When They Fail 87
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 87
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 87
[Hepatitis B virus infection in a hospital population in Parma: implementation of a vaccination program] 86
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection 86
Cellular immune response to hepatitis B virus antigens. An overview 85
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 85
Reorganization of a large academic hospital to face COVID-19 outbreak: The model of Parma, Emilia-Romagna region, Italy 85
Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C [5] 85
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 84
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection 84
Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for the screening of bacterial peritonitis 84
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 84
Subacute thyroiditis after tick bite 83
Comparative pathogenesis of HBV and HCV 83
Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. 83
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 83
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 83
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 82
Totale 11.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021427 0 0 0 0 0 46 53 40 123 72 58 35
2021/2022816 23 17 7 48 74 58 47 88 48 26 30 350
2022/20233.180 406 247 168 205 222 361 43 188 1.126 16 142 56
2023/20241.476 82 144 61 76 121 350 92 120 59 89 91 191
2024/20254.869 104 271 290 244 543 595 235 225 660 422 389 891
2025/20265.298 859 1.072 1.102 765 1.303 197 0 0 0 0 0 0
Totale 19.137